| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2007 | CN1891217A Use of applepolyphenol for preparing medicine fortreating prostatitis or prostatic hyperplasia |
| 01/10/2007 | CN1891216A Use of catechin and its derivates for preparing medicine for preventing and treating neurodegenerative disease |
| 01/10/2007 | CN1891215A Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/10/2007 | CN1891214A Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/10/2007 | CN1891213A Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions |
| 01/10/2007 | CN1891212A Oral preparation and its preparing method |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1891210A Ranitidine bismuth citrate dispersible tablet, and its preparing method |
| 01/10/2007 | CN1891209A Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 01/10/2007 | CN1294142C 17 beta-carbothioate 17 alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/10/2007 | CN1294141C 6 alpha., 9 alpha-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/10/2007 | CN1294136C Novel ligand for nicotinic acety/choline receptors useful in therapy |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294134C Cyclohexylphenyl vasopression agonists |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294132C Synthesis of temozolomide and analogs |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294130C Substituted pyrazoles |
| 01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
| 01/10/2007 | CN1294120C Pyrrolidinyl metalloprotease inhibitor and its application |
| 01/10/2007 | CN1294118C Meso cryptoxanthine preparation |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293921C Long-term effective injection containing ethylcellulose and fatty acid ester |
| 01/10/2007 | CN1293915C Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium |
| 01/10/2007 | CN1293907C Health product for improving skin moisture content and preparation method thereof |
| 01/10/2007 | CN1293901C Chinese medicinal preparation for resisting herpes virus and preparing method thereof |
| 01/10/2007 | CN1293897C Burn- and scald-treating powder |
| 01/10/2007 | CN1293890C Ointment of Chinese traditional medicine for treating hyperplasia of mammary glands, and preparation method |
| 01/10/2007 | CN1293885C High-permeability burn-treating preparation |
| 01/10/2007 | CN1293884C Application of 6-methocy bideoxy bideoxy guanosine in preparation of medicine for resisting hepatitis B |
| 01/10/2007 | CN1293883C Beautifying liquid and preparation method thereof |
| 01/10/2007 | CN1293882C Compound phytosterol with serum cholesterol-reducing action and preparing process thereof |
| 01/10/2007 | CN1293881C Compound antitussive |
| 01/10/2007 | CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/10/2007 | CN1293879C Freeze-dried powder injection of pantoprazole sodium and its preparation |
| 01/10/2007 | CN1293878C Preventing or therapeutic agent for eye fatigue and pseudomyopia |
| 01/10/2007 | CN1293877C Neurotrophic tacrolimus analogs |
| 01/10/2007 | CN1293876C New use of 1,3-propylene glycol derivative |
| 01/10/2007 | CN1293875C Cell growth regulating factor S and its preparation process |
| 01/10/2007 | CN1293874C Traditional Chinese medicine Monascus purpureus went using Lovastatin salt as main active component and its preparation component |
| 01/10/2007 | CN1293873C Andrographis herb preparation |
| 01/10/2007 | CN1293872C Oral cavity local administered pharmaceutical composition for treating pharyngitis and preparation method thereof |
| 01/10/2007 | CN1293871C Wild apple polyphenol and process for producing the same |
| 01/10/2007 | CN1293870C Medicine for treating osteoporosis and its preparing method |
| 01/10/2007 | CN1293869C Method and composition for delivering zinc to the nasal membrane |
| 01/10/2007 | CN1293868C Application of alpha cyclo-alanine in the process for preparing medicine to treat cerebrovascular and cardiovascular disease |
| 01/10/2007 | CN1293867C Medicinal compound preparation |
| 01/10/2007 | CN1293866C Cell growth regulating factor II and its preparation process |
| 01/10/2007 | CN1293865C Cell growth regulating factor R and its preparation process |
| 01/10/2007 | CN1293864C Topical formulations containing ketoprofen stabilised with sulisobenzone |
| 01/10/2007 | CN1293863C Ibolite fumarate nasal cavity administration preparation |
| 01/10/2007 | CN1293855C Tooth whitening products |
| 01/10/2007 | CN1293825C Application of dihydromyricetin in preparation of food, cosmetics or medicine |
| 01/09/2007 | USRE39464 Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/09/2007 | US7161034 Lidocaine analogs and methods of making and using same |
| 01/09/2007 | US7161033 E.g., 2S [[(N-methylamino)acetyl]amino]-N-[2R-hydroxy-3-[[(1,3-benzodioxol-5-yl)sulfonyl](2-methylpropyl)amino]-1S-(phenylmethyl)propyl]-3,3-dimethyl-butanamide; in particular as inhibitors of HIV protease |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
| 01/09/2007 | US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 01/09/2007 | US7161002 Compounds as antiinflammartory agents, antiproliferation agents and and anticancer agents from cyclodehydration of compounds |
| 01/09/2007 | US7160999 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 01/09/2007 | US7160992 Amino-modified polysaccharides and methods of generating and using same |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160922 Biphenyl-4-carboxylic acid-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2-hydroxyindan-1-yl)amide; cognitive activators, attention deficit/hyperactivity disorder, obesity, Alzheimer's disease, psychoses, schizophrenia; hypotensive agents for glaucoma |
| 01/09/2007 | US7160921 Reduction of hair growth |
| 01/09/2007 | US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 01/09/2007 | US7160919 C7 lactyloxy-substituted taxanes |
| 01/09/2007 | US7160917 Prepared by fermentation by microorganism Stachybotris; anticoagulants, anticarcinogenic, antitumor, antidiabetic, and antihypoxic agents; cardiovascular disorders, angina pectoris, septic shock, arteriosclerosis |
| 01/09/2007 | US7160916 Method of increasing bone density or treating osteoporosis |
| 01/09/2007 | US7160915 N-methyl-substituted benzamidazoles |
| 01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 01/09/2007 | US7160913 Methods and kit for treating Parkinson's disease |
| 01/09/2007 | US7160912 Oxazolidinone derivative of the formula (I) or a salt thereof, or a stereoisomer thereof, where R1 represents NHR4 wherein R4 represents thio(C1-C10)acyl, C( . dbd. S)-cyclo(C3-C8)alkoxy, C( .dbd. S) (C1-C10)alkoxy, C( .dbd.S |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/09/2007 | US7160910 Anti-sickling agents |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160908 Platinum amine glycine complex derivatives; antiproliferative and antitumor agents; side effect reduction; reversibly active; on and off |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160905 Hydroxyethylene compounds with Asp2 inhibitory activity |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160902 Amide derivatives and methods of their use |
| 01/09/2007 | US7160901 Antiproliferative agents; antitumor agents; kinase inhibitors |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
| 01/09/2007 | US7160898 Pharmacological treatment for sleep apnea |
| 01/09/2007 | US7160897 Therapeutic compounds |
| 01/09/2007 | US7160896 Therapeutic acridone and acridine compounds |
| 01/09/2007 | US7160895 Inhibiting the proliferation of tumor cells, using 6-chloro-1,9-dimethyl-3-phenyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; anticancer treatment |
| 01/09/2007 | US7160894 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 01/09/2007 | US7160890 N-6 Substituted 7-deazapurines selectively binding to the adenosine 3 receptor; bronchitis, gastrointestinal disorders, asthma, allergic rhinitis, chronic obstructive pulmonary disease, vision defects, arthritis, autoimmune disease |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160888 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human |
| 01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
| 01/09/2007 | US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 01/09/2007 | US7160885 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity |